Cisplatin, fluorouracil, celecoxib, and RT in resectable esophageal cancer: preliminary results.

Oncology (Williston Park, N.Y.)

Volumn 18, Issue 14 Suppl 14, 2004, Pages 18-21

  Govindan, Ramaswamy ^a   McLeod, Howard ^a   Mantravadi, Prasad ^a   Fineberg, Naomi ^a   Helft, Paul ^a   Kesler, Kenneth ^a   Hanna, Nasser ^a   Stoner, Cindy ^a   Ansari, Rafat ^a   Fox, Edward ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CELECOXIB; CISPLATIN; FLUOROURACIL; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ADENOSQUAMOUS CARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; SQUAMOUS CELL CARCINOMA; SURVIVAL; TIME;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYCLOOXYGENASE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PYRAZOLES; RADIOTHERAPY, ADJUVANT; SULFONAMIDES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 17944362255     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)